Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Showing 20 of 0 results

Not applicableUnknownNCT06041620
What this trial is testing

Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells

Who this might be right for
Thalassemia, BetaThalassemia Major
Institute of Hematology & Blood Diseases Hospital, China 2
Large-scale testing (Phase 3)Study completedNCT00872170
What this trial is testing

Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension

Who this might be right for
ThalassemiaHypertension, Pulmonary
Carelon Research 27
Early research (Phase 1)Study completedNCT04285827
What this trial is testing

Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
CSL Behring 28
Testing effectiveness (Phase 2)Study completedNCT00790127
What this trial is testing

Phase 1/2 Study of HQK-1001 in Patients With Beta Thalassemia

Who this might be right for
Beta Thalassemia
HemaQuest Pharmaceuticals Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00001197
What this trial is testing

Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia

Who this might be right for
Sickle Cell Anemia
National Heart, Lung, and Blood Institute (NHLBI) 41
Not applicableStudy completedNCT05952817
What this trial is testing

Effect of Virtual Reality on Pain and Function in Children With Sickle Cell Disease: A Randomized Controlled Trial

Who this might be right for
SCD
Afnan Bkri 40
Testing effectiveness (Phase 2)Looking for participantsNCT04143724
What this trial is testing

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Who this might be right for
Beta-Thalassemia
Celgene 99
Testing effectiveness (Phase 2)UnknownNCT02453477
What this trial is testing

Gene Therapy for Transfusion Dependent Beta-thalassemia

Who this might be right for
Beta-Thalassemia
IRCCS San Raffaele 10
Early research (Phase 1)Study completedNCT00712738
What this trial is testing

Oral Nifedipine to Treat Iron Overload

Who this might be right for
ThalassemiaIron OverloadHemochromatosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 6
Not applicableStudy completedNCT02709681
What this trial is testing

Hydroxyurea in the Treatment of Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Società Italiana Talassemie ed Emoglobinopatie 628
Large-scale testing (Phase 3)WithdrawnNCT01206907
What this trial is testing

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Who this might be right for
Chronic Pain
Endo USA Inc., a Keenova Therapeutics Company
Testing effectiveness (Phase 2)Study completedNCT01140321
What this trial is testing

Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI

Who this might be right for
OsteoporosisThalassemia MajorThalassemia Intermedia
Ente Ospedaliero Ospedali Galliera 120
Large-scale testing (Phase 3)Study completedNCT00171821
What this trial is testing

A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload

Who this might be right for
Transfusion-dependent Iron Overload
Novartis Pharmaceuticals 1,784
Large-scale testing (Phase 3)Study completedNCT03745287
What this trial is testing

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseHematological DiseasesHemoglobinopathies
Vertex Pharmaceuticals Incorporated 63
Not applicableUnknownNCT02573714
What this trial is testing

Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises

Who this might be right for
Sickle Cell Disease
Cameroon Baptist Convention Health 160
Not applicableLooking for participantsNCT06944067
What this trial is testing

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Human Genome Research Institute (NHGRI) 50
Testing effectiveness (Phase 2)WithdrawnNCT00850369
What this trial is testing

A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionSickle Cell Disease
University of North Carolina, Chapel Hill
Not applicableStudy completedNCT02729350
What this trial is testing

The Feasibility of the PAINReportIt Guided Relaxation Intervention-INPATIENT

Who this might be right for
Sickle Cell DiseaseStressPain
University of Florida 46
Post-approval studies (Phase 4)Ended earlyNCT00252122
What this trial is testing

Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Children's Hospital of Philadelphia 3
Testing effectiveness (Phase 2)Enrolling By InvitationNCT04432623
What this trial is testing

The BENeFiTS Trial in Beta Thalassemia Intermedia

Who this might be right for
Beta Thalassemia IntermediaSickle Cell Disease
Phoenicia BioScience 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation